The French Health Care System Challenged by the Over-Sea??: Some Inequalities in French Guyana, Espace populations soci??t??s, issue.2009/1, pp.175-189, 2001. ,
DOI : 10.4000/eps.3638
Tableaux économiques régionaux de la Guyane, pp.12-13, 2010. ,
fièvre au cours le l'infection par le VIH dans l'ouest Guyanais, 2010. ,
La Communaité de Communes de l'Ouest Guyanais : un territoire jeune et attractif à développer, INSEE, 2009. ,
Choses de la forêt, Identité et thérapie chez les Noirs Marrons Ndjuka du Surinam, pp.261-281, 1993. ,
Rapport d'activité CISIH 2006 : point sur la prise en charge du VIH en Guyane, 2007. ,
Pattern of neuropsychological performance among HIV positive patients in Uganda, BMC Neurology, vol.33, issue.1, p.8, 2007. ,
DOI : 10.1097/00126334-200305010-00018
« Comment dépister et prendre en charge les troubles neuro-cognitifs? »Quels enjeux pour les patients VIH ?, in X ème Congrès National de la Société Françaisede Lutte contre le Sida, SFLS, 2009. ,
The prevalence and incidence of neurocognitive impairment in the HAART era, AIDS, vol.21, issue.14, pp.1915-1936, 2007. ,
DOI : 10.1097/QAD.0b013e32828e4e27
Attenuated Central Nervous System Infection in Advanced HIV/AIDS With Combination Antiretroviral Therapy, Archives of Neurology, vol.61, issue.11, pp.61-1687, 2004. ,
DOI : 10.1001/archneur.61.11.1687
Updated research nosology for HIV-associated neurocognitive disorders, OMS, VIH/Sida et santé mentale, pp.69-1789, 2007. ,
DOI : 10.1212/01.WNL.0000287431.88658.8b
Medication adherence in HIV-infected adults, AIDS, vol.18, issue.Supplement 1, pp.19-25, 2004. ,
DOI : 10.1097/00002030-200401001-00004
prise en charge médicale des personnes infectées par le VIH. 2010, la documentation française, pp.132-134 ,
The International AIDS Society?USA: Washington. 16 Neurodegeneration and ageing in the HAART era, Decades On J Neuroimmune Pharmacol, issue.42, pp.163-74, 2009. ,
Correlates of CSF viral loads in 1221 volunteers of the CHARTER Cohort, 17th CROI 2010. Abstract 172, 2010. ,
Système nerveux et VIH : «Charter» pour la CROI. Transcriptase, 2009. 141. 19 Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia, Ann Neurol, issue.2, pp.55-257, 2004. ,
Troubles neurocognitifs dans le VIH, 2010. ,
les tests cognitifs : éléments de diagnostic et de suivi, in pourquoi et comment traiter un patient agé dément ?, p.22, 2008. ,
Migrations et soins en Guyane Agence française de développement, p.31, 2009. ,
The International HIV Dementia Scale: a new rapid screening test for HIV dementia, Aids, vol.19, issue.13, pp.1367-74, 2005. ,
and progression of HIV-associated neurocognitive impairment (NCI) in the era of combination antiretroviral therapy (CART) and the role of comorbidities: the CHARTER study, 5th IAS Conference on HIV Pathogenesis and Treatment, 2009. ,
The International HIV Dementia Scale Is a Useful Screening Tool for HIV-Associated Dementia/Cognitive Impairment in HIV-Infected Adults in Yaound??-Cameroon, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.49, issue.4, 2008. ,
DOI : 10.1097/QAI.0b013e318183a9df
Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study 13: p. 15. 27 Good neurocognitive performance measured by the international HIV dementia scale in early HIV-1 infection High prevalence of mild neurocognitive disorders in HIV-infected patients, ANRS CO3 Aquitaine Cohort, 16th CROI 2009 Abstract 474, pp.488-922, 1996. ,
Episodic and Working Memory Deficits in Alcoholic Korsakoff Patients: The Continuity Theory Revisited, Alcoholism: Clinical and Experimental Research, vol.34, issue.Pt 1A, pp.32-1229, 2008. ,
DOI : 10.1111/j.1530-0277.2008.00677.x
HIV DNA and Dementia in Treatment-Na??ve HIV-1-Infected Individuals in Bangkok, Thailand, International Journal of Medical Sciences, vol.4, issue.1, pp.13-21, 2007. ,
DOI : 10.7150/ijms.4.13
Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance, AIDS, vol.23, issue.11, pp.1359-66, 2009. ,
DOI : 10.1097/QAD.0b013e32832c4152
Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy, Neurology, vol.73, issue.5, pp.342-350, 2009. ,
DOI : 10.1212/WNL.0b013e3181ab2b3b
The impact of HIV-associated neuropsychological impairment on everyday functioning, Journal of the International Neuropsychological Society, vol.56, issue.03, pp.317-348, 2004. ,
DOI : 10.1016/0887-6177(93)E0005-V